SRI-22819 is NF-ҡB activator for the treatment of ALS. SRI-22819 increases NF-ҡB expression and activation in vitro, but it has poor ADME properties in general and has no oral bioavailability.
MedKoo Cat#: 123390
Name: SRI-22819
CAS#: N/A
Chemical Formula: C14H12N4S
Exact Mass: 268.0800
Molecular Weight: 268.34
Elemental Analysis: C, 62.66; H, 4.51; N, 20.88; S, 11.95
The following data is based on the product molecular weight 268.34 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
